Morrison Jodie Pope
SEC insider (Form 3/4/5 filer). CIK 0001618247. CEO at Q32 Bio Inc. (QTTB) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in WALTHAM, MA.
Companies Morrison Jodie Pope has filed insider reports for
- Q32 Bio Inc. (QTTB): Director, Officer, CEO
- Verve Therapeutics, Inc. (VERV): Director
Morrison Jodie Pope
CIK: 0001618247
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 6, 2026QTTB
Q32 Bio Inc.
SaleDirect3.2K shares at avg. $8.32$27K - Aug 25, 2026QTTB
Q32 Bio Inc.
SaleDirect9.8K shares at avg. $16.56$163K - Jul 16, 2026QTTB
Q32 Bio Inc.
AwardDirect132K shares- - Feb 25, 2026QTTB
Q32 Bio Inc.
SaleDirect9.9K shares at avg. $4.51$45K - Feb 24, 2026QTTB
Q32 Bio Inc.
AwardDirect132K shares- - Dec 2, 2025QTTB
Q32 Bio Inc.
SaleDirect22.5K shares at avg. $3.46$78K - Aug 26, 2025QTTB
Q32 Bio Inc.
SaleDirect10.5K shares at avg. $1.80$19K - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
42.2K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
267.5K shares- - Jun 5, 2025VERV
Verve Therapeutics, Inc.
AwardDirectStock Option (right to buy)
42.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  QTTB Q32 Bio Inc. | Sale | 3,221 | $8.32 | $26,798 | Direct |
| Aug 25, 2026 | QTTB Q32 Bio Inc. | Sale | 9,845 | $16.56 | $163,033 | Direct |
| Jul 16, 2026 | QTTB Q32 Bio Inc. | Award | 132,000 | - | $0 | Direct |
| Feb 25, 2026 | QTTB Q32 Bio Inc. | Sale | 9,896 | $4.51 | $44,675 | Direct |
| Feb 24, 2026 | QTTB Q32 Bio Inc. | Award | 132,000 | - | $0 | Direct |
| Dec 2, 2025 | QTTB Q32 Bio Inc. | Sale | 22,506 | $3.46 | $77,871 | Direct |
| Aug 26, 2025 | QTTB Q32 Bio Inc. | Sale | 10,494 | $1.80 | $18,900 | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 42,200 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 267,541 | - | - | Direct |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | Award Stock Option (right to buy) | 42,200 | - | - | Direct |
1-10 of 15 transactions